Wear particle-induced periprosthetic osteolysis is the primary complication of the total joint replacement; however, no conservative treatment except for reversal surgery is available for this disease. During the past decade, Chinese herbal medicines have been widely investigated to inhibit osteoclast differentiation, which may exhibit the potential to treat wear particle-induced periprosthetic osteolysis. The present study was aimed at the investigation of the effects of forsythiaside on osteocytes. The current data revealed that the forsythiaside treatment notably inhibited the titanium (Ti) particle-induced inflammation through impaired NF-kB signaling, thereby inhibiting TNF-a and IL-1b. In addition, the in vitro study demonstrated that forsythiaside effectively prevented the RANKL-induced differentiation of osteoclasts and inhibited the expression of osteoclast-specific genes in osteoclasts via inhibition of the JNK signaling pathway.
Introduction
With the aging population and the demand for high-quality life, the number of individuals that undergo arthroplasty is increasing since it is an effective treatment for severe trauma and arthritic joint diseases.
1 Due to their excellent biocompatibility, titanium (Ti) and its alloys have widespread applications in prostheses. However, aseptic prosthetic loosening, one of the long-term complications aer joint arthroplasty, limits the longevity of the prostheses.
2 Wear particles, released from prosthetic implants, are speculated to play a crucial role as corrosive products and reactive oxygen species, which ultimately induce an inammatory reaction; 3, 4 currently, only a few drugs are available that can effectively treat or alleviate bone resorption surrounding the prosthetic implant and thus would aid in understanding the underlying formation mechanism and promoting the related functional studies.
T lymphocytes, broblasts, macrophages, and foreign body giant cells are stimulated by wear particles to produce a vast array of pro-inammatory cytokines, which would induce the expression of RANKL by osteoblasts and marrow stromal cells.
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Accumulating evidence has demonstrated that the formation of osteoclasts is mainly determined by two key factors, i.e., macrophage colony-stimulating factor (M-CSF) and receptor activator for the nuclear factor-kB ligand (RANKL), which is the key factor for osteoclast differentiation. 6 During the activation of osteoclastogenesis, ve signaling cascades mediated by protein kinases are activated: an inhibitor of NF-kB kinase (IKK), c-Jun N-terminal kinase (JNK), p38, extracellular signalregulated kinase (ERK), and the Src pathway. 7, 8 Numerous studies have described that the activation of the RANK and the RANKL signaling pathways elevates osteoclastogenesis, which leads to osteolysis around the prosthesis. [9] [10] [11] Hence, targeting the osteoclastogenesis might be a promising approach for the treatment of periprosthetic osteolysis.
Several studies have focused on the use of Chinese herbs to inhibit osteoclast differentiation; for example, icariin prevents the Ti particle-induced inhibition of osteogenic differentiation in MSCs, 12 melatonin prevents Ti particle-induced inammatory bone resorption and osteoclastogenesis via suppression of the NF-kB signaling and the activation of the Wnt/b-catenin signaling pathway, 13, 14 and myricetin inhibits RANKL-induced osteoclastogenesis in vitro and prevents the Ti particle-induced osteolysis in vivo. 15 Thus, Chinese herbs might exhibit a great potential in the treatment of Ti particle-induced osteolysis.
Forsythiaside, a traditional Chinese medicine, is widely used for heat clearing and detoxication. It contains a variety of ester glycosides, of which, forsythiaside is an effective active ingredient. 16, 17 In addition, it has a wide spectrum of properties along with robust antibacterial efficiency against Staphylococcus aureus.
18,19 Surprisingly, in our previous studies, we have found that forsythiaside exerts a signicant inhibitory effect on osteoclast activity; although the inhibitory effect of forsythiaside on the osteoclast activity has been conrmed, the underlying mechanism of action and the in vivo effects are not yet claried. In view of the bacterial erosion of postoperative bone infections and the pathological state of the massive activation of osteoclasts in an inammatory environment, forsythiaside effectuates broadspectrum antibacterial properties and the dual efficacy of inhibiting osteoclasts, thereby rendering it as an ideal drug for the prevention and treatment of post-plant infections. 20 Thus, we induced osteocyte apoptosis and investigated the effects of forsythiaside on apoptotic osteocytes and subsequent osteoclastogenesis in vitro and in vivo. Based on the results obtained herein, we speculated that forsythiaside might be a novel candidate for the treatment of periprosthetic osteolysis.
Material and methods

Materials
Titanium (Ti) particles (Johnson Matthey), mouse macrophage RAW264.7 cells (ATCC, American), alpha minimum essential medium (a-MEM; Hyclone), fetal bovine serum (FBS; Gibco, Australia), CCK-8 kit (Dongjido, Japan), trypsin-EDTA (0.5%), penicillin, streptomycin (Gibco, Australia), forsythiaside (Solarbio, China), Trizol reagents (Life Technologies, Australia), RNeasy Mini Kit (Qiagen). Trizol (Invitrogen), RIPA (Beyotime biotechnology), TRAP staining kit (Sigma), mouse RANKL and M-CSF (R&D), MAPK Family Antibody Sampler Kit and NF-kB Family Member Antibody Sampler Kit (Cell signaling technology), cDNA synthesis kit, real-time PCR kit (SYBR Premix EX Taq, TaKaRa), Pierce™ bicinchoninic acid (BCA) protein assay kit (ThermoFisher), and TNF-a ELASA kit and IL-1b ELISA kit (R&D).
Methods
BMM extraction and osteoclast differentiation. We isolated bone marrow-derived macrophages (BMMs) from the femur and tibia bone marrow of 5 week-old C57BL/6 mice. Freshly isolated BMMs were cultured in a T75 ask in a-MEM forsythiaside at different concentrations (0, 25, or 50 mM). The culture medium was replaced every 2 days until mature osteoclasts had formed. The cells were xed with 4% paraformaldehyde for 20 min and stained for TRAP using the Diagnostic Acid Phosphatase Kit. The TRAP-positive cells with more than three nuclei were counted as osteoclast-like cells. The BMM cells (2.4 Â 10 4 cells per cm 2 ) were seeded on the bovine bone slices. Aer 48 h, the BMM cells were stimulated with 50 ng mL À1 RANKL, 30 ng mL À1 M-CSF, and forsythiaside (0, 25, or 50 mM) until mature osteoclasts were formed. Then, the cells were removed by mechanical agitation and sonication. The resorption pits were visualized using a scanning electron microscope (SEM, FEI Quanta 250). Herein, three elds of view were randomly selected for each bone slice for further analysis, and the bone surface resorption area was quantied using the Image J soware (National Institutes of Health, MD, USA). RNA extraction and quantitative real-time PCR. We used quantitative real-time PCR to analyze the specic gene expression during osteoclast formation. The BMM cells obtained from the C57BL/6 mice were seeded in 24-well plates at the density of 1 Â 10 5 cells per well. Then, the BMM cells were stimulated with RANKL, M-CSF, and different doses of forsythiaside (0, 25, or 50 mM) for 5 days. Following the manufacturer's instructions, RNA was extracted using TRIzol, and cDNA was reverse transcribed from 1 mg of total RNA using reverse transcriptase. Real-time PCR was performed using SYBR1 Premix ExTaq™ II and the ABI 7500 Sequencing Detection System (Applied Biosystems, Foster City, CA, USA). The following cycling conditions were used: 40 cycles of denaturation at 95 C for 5 s and amplication at 60 C for 24 s. GAPDH served as a housekeeping gene. The mouse primer sequences for TRAP, cathepsin K (CTSK), calcitonin receptor (CTR), V-ATPase-d2, V-ATPase-a3, NFATc1, DC-STAMP, and GAPDH are listed in Table 1 .
Western blotting. The RAW 264.7 cells were seeded in 6-well plates at the density of 6 Â 10 5 cells per well and pretreated with or without forsythiaside (25 mM) for 10 min, 20 min, 30 min, and 1 h; then, they were stimulated with RANKL and M-CSF. When the osteoclasts had formed, we extracted total proteins from these cells using the radioimmunoprecipitation assay (RIPA) lysis buffer. The cells were then separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to polyvinylidene diuoride (PVDF) membranes. Subsequently, the membranes were blocked with 5% skimmed milk in TBST for 1 h and probed with different antibodies, followed by incubation with appropriate HRP-conjugated secondary antibodies. Finally, according to the manufacturer's instructions, the membrane was developed by enhanced chemiluminescent (ECL) reagents and imaged using Image Quant LAS 4000 (GE Healthcare, Silverwater, Australia). Quantication was obtained from phosphorylated proteins as compared to the total proteins and then normalized to the control group. Cell viability assay of forsythiaside on the THP-1 cell and inhibition of Ti particle-induced inammation by forsythiaside. The human macrophage cell line THP-1 was obtained from the Chinese Academy of Sciences and cultured in an RPMI 1640 medium supplemented with 10% FBS at 37 C in a humidied 5% CO 2 incubator. The THP-1-deprived macrophages were induced with phorbol myristate acetate (PMA) at the concentration of 100 ng mL À1 for 12 h. The effect of forsythiaside on the viability of THP-1-deprived macrophages was determined by the CCK-8 assay according to the previous method. Then, we determined the mRNA levels of inammation-related and macrophage polarization-related genes, including TNF-a and IL1b, on day 3 of the incubation of the THP-1-deprived macrophage in forsythiaside (50 mM)-treated groups as compared to those in the control group, Ti particle and forsythiaside and Ti particle co-treated group. Moreover, the inammatory cytokine secretion was examined on day 3 of the culture with TNF-a and IL-1b ELISA kit. The IkBa and p-IkBa were also detected in forsythiaside and Ti particle co-treated groups as compared to the case of the Ti particle-treated group, forsythiaside (50 mM)-treated group and RANKL-treated group via western-blotting assay.
Micro-computed tomography (CT) scanning, histological, and histomorphometry analysis. A particle-induced periimplant-associated osteolysis rat model was established. Briey, a Ti implant (1.5 mm Â 10 mm) was implanted laterally into the femoral condyle, and then, Ti particles were injected into the tissue around the implant. Aer 4 weeks post-surgery, the rats were sacriced, and femurs were harvested under sterile conditions. Next, a high-resolution micro-CT (Skyscan, Belgium) was employed to analyze the femoral condyle. The scanning protocol was set at the isometric resolution at 20 mm and X-ray energy settings of 80 kV and 80 mA. Aer reconstruction, a square region of interest (ROI) around the midline suture was selected for further qualitative and quantitative analyses. Bone volume/tissue volume (BV/TV), the number of porosities, and the percentage of total porosity of each sample were measured, as reported previously.
Statistical analysis. The obtained results were analyzed by the SPSS 13.0 soware (IBM) and expressed as mean AE SD. P < 0.05 was considered as a signicant difference between groups. The experiments were carried out at least three times.
Results
BMM cell viability and cytotoxicity assay for the effect of forsythiaside
The CCK-8 assay was used to determine the cell viability of forsythiaside on BMMs. As shown in Fig. 1 , cell viability was not altered in the presence of <50 mM but was inhibited at 100 mM concentration of forsythiaside. To further examine the effect of forsythiaside on cell apoptosis, the BMM cells were incubated with various doses of the drug and stained with annexin V and PI. Furthermore, the drug at the dosage of 10-50 mM did not induce either necrosis or apoptosis pathways in the BMM cells (Fig. 1) .
TRAP staining and bone slice resorption pit of forsythiasideinhibited osteoclastogenesis in vitro
Next, we investigated the effect of forsythiaside on osteoclast formation via TRAP staining and bone slice resorption pit. BMMs were cultured in a 96-well plate and then treated with 30 ng mL À1 M-CSF and 50 ng mL À1 RANKL in the presence or absence of forsythiaside at different concentrations for 5 days. As shown in Fig. 2 , a large number of TRAP-positive osteoclasts were formed in the blank group. However, the number of mature osteoclasts was signicantly decreased in the forsythiaside-treated cells. Importantly, forsythiaside inhibited osteoclastogenesis in a dose-dependent manner. Approximately, 60% fewer TRAP-positive osteoclasts were observed in the cells treated with 50 mM forsythiaside ( Fig. 2A) . Furthermore, we investigated the osteoclast bone resorption aer the addition of forsythiaside at varying concentrations in the culture media for 5 days. Bone slices were selected and prepared for scanning electron microscopy (SEM). As shown in Fig. 2C and D, scattered bone resorption pits were observed on the surface of bone slices in the control group. On the other hand, the resorption area was decreased to 30% and <20% aer treatment with 25 and 50 mM forsythiaside, respectively. Moreover, almost no resorption pits were observed in the slices treated with 50 mM forsythiaside. Thus, these ndings suggested that forsythiaside impaired the osteoclast bone resorption in vitro.
Real-time PCR for the osteoclast differentiation of forsythiaside
Subsequently, we used quantitative PCR (qPCR) to analyze and quantify the RANKL-induced mRNA expression of osteoclastrelated genes (including TRAP, CTR, CTSK, dendritic cellspecic transmembrane protein (DC-STAMP), V-ATPase a3, VATPase d2, and NFATC1) to conrm the inhibitory effects of forsythiaside on osteoclast formation. As shown in Fig. 3 , the osteoclast-related gene expression was suppressed by forsythiaside in a dose-dependent manner. These data further conrmed that forsythiaside suppressed the osteoclast formation and inhibited the expression of the osteoclastspecic genes.
Western-blotting for the investigation of the ERK, JNK, p38 signaling pathways
Western blotting was employed to investigate the potential signaling pathways underlying the osteoclast differentiation aer forsythiaside intervention. The RAW264.7 cells were treated with RANKL in the presence or absence of forsythiaside, and then, the JNK, ERK, and p38 signaling pathways were examined using specic antibodies. The phosphorylation of JNK, ERK, and p38 was increased within 10-60 min aer stimulation with RANKL in the control group. However, the ERK, JNK, and p38 phosphorylations were signicantly inhibited aer the treatment of cells with forsythiaside and aer stimulation with RANKL and forsythiaside (Fig. 4) . The total protein ERK1/2 was different at 10 minutes, 20 minutes, and 30 minutes. Although there was no signicant difference in p-ERK1/2, the quantitative data showed a difference when the data obtained at 10 min, 20 min, and 30 min were compared (Fig. 4) . A signicant difference in p-JNK/JNK appeared at 10 min and 60 min, and a substantial change in p-p38/p38 appeared at 20 min and 30 min (Fig. 4) . Altogether, these data suggested that forsythiaside inhibited osteoclastogenesis by primarily targeting the ERK, JNK, and p38 signaling pathways.
Inhibition of Ti particle-induced inammation
The CCK-8 assay was used to determine the cell viability of forsythiaside on THP-1. Fig. 5E demonstrates that the THP-1 cell viability has not been affected in the presence of forsythiaside at <50 mM. We determined the mRNA levels of inammation-related and macrophage polarization-related genes, including TNF-a and IL-1b, on day 3 of incubation in the forsythiaside-treated groups as compared to those in the control group (Fig. 5A and B) . Moreover, the inammatory cytokine secretion was examined on day 3 of culture. The expression of the inammatory cytokines TNF-a and IL-1b decreased in the presence of forsythiaside at low or high concentrations ( Fig. 5C and D) ; this demonstrated that macrophages in contact with Ti particles triggered an inammatory microenvironment that increased the inltration of macrophages and the release of inammatory mediators. On the other hand, the addition of forsythiaside inhibited the expression of TNF-a and IL-1b genes and the release of TNF-a and IL-1b inammatory cytokines. Furthermore, western blotting demonstrated that forsythiaside administration decreased the NF-kB activation and the levels of p-IkBa; this, in turn, increased the production of the inhibitor of NF-kB (IkBa) and inhibited the downstream activation of NF-kB and the secretion of inammatory cytokines, TNF-a and IL-1b. The FA + Ti particles at 30 min obviously provided highest p-IKB-alpha; this suggested that the highest NFkB signaling levels mainly resulted from the Ti particles (Fig. 5F ). However, aer 15 min, the p-IKB-alpha signicantly reduced; this suggested the reduction of the NFkB signaling levels. We speculated that forsythiaside might have a delayed effect on the NFkB signaling levels. 
Micro-CT for the characterization of Ti particle-induced osteolysis
The effect of forsythiaside on Ti particle-induced implantassociated osteolysis was examined in a SD rat model. Micro-CT with three-dimensional reconstruction revealed an extensive bone resorption in the Ti particle group. In the groups with forsythiaside intervention, particle-induced implant-associated osteolysis was inhibited in a dose-dependent manner, whereas bone resorption in mice treated with forsythiaside at high concentrations was much lower than that at low concentrations. BV/TV, the number of porosities, and the percentage of total porosity in the ROI were measured based on the threedimensional reconstruction images as reported previously. Compared to the case of the sham control, the presence of Ti particles induced signicant osteolysis in the implant around the bone tissue (Fig. 6) . When forsythiaside was injected at 5 mg kg À1 and 10 mg kg À1 daily, the osteolytic bone loss was prevented as compared to the case of the Ti particle group.
Discussion
Orthopedic implant-associated osteolysis is the primary drawback of implant failure in the long-term, especially with respect to the prosthetic replacement. Although the pathogenesis of the orthopedic implant-associated osteolysis is widely investigated, no efficient clinical measure is yet available.
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Several factors contribute to the process of implantassociated osteolysis. 22 In addition, the cytokines of the innate immune system play a vital role in the pathology of orthopedic implant failure. 23, 24 The basic biological mechanism of aseptic loosening includes the stimulation of the wear particles on the surrounding macrophages to produce a series of inammatory factors (TNF-a, IL-1b, and IL-6) upon chronic inammation; these inammatory factors can stimulate the osteoclast differentiation and maturation. In addition, the osteogenic differentiation and function are inhibited, and the inammatory cells accumulate in the lesion, exerting a cascade effect, eventually causing osteolysis around the implant. As described previously, forsythiaside inhibited the LPS-induced inamma-tory factors IL-6, IL-1b, and TNF-a and the production of Cox-2 via the inactivation of NF-kB. 25 Furthermore, forsythiaside attenuated the Ti-induced activation of NF-kB signaling, targeting the IkB kinase-a (IKKa) of macrophages and inuencing the expression of NF-kB downstream inammatory cytokines.
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On the other hand, excessive osteoclast differentiation, originating from the wear particles, plays a critical role in the process of osteoclastogenesis. RANKL-induced osteoclastogenesis is the main pathway in the formation of mature osteoclasts. Aer RANKL binds to RANK, the downstream cascade of TRAF-6 and TAK1 is activated; moreover, the activated TAK1 phosphorylates both IkB kinase (IKK) and MAPK kinases (MKKs); this, in turn, stimulates the NF-kB and MAPK signaling pathways, critical for osteoclastogenesis. 27 In the present study, forsythiaside inhibited the RANKL-induced osteoclastogenesis and Ti particle-induced periprosthetic osteolysis via JNK signaling. Wear debris upregulated the various pro-inammatory cytokines and chemokines in a range of cell types such as macrophages, osteoclast precursor cells, osteoblasts, and lymphocytes, which were at the interface between the implants and the surrounding bone. Together, these cells could affect the other cells through distinct signaling mechanisms. The inammatory environment would accelerate osteoclast differentiation. Thus, the ideal target of inhibition of wear particles associated osteolysis including the inhibition of particles-induced inammation; RANKL-induced osteoclastogenesis and Ti particle-induced periprosthetic osteolysis. In the present study, forsythiaside inhibited the Ti particle-induced inammation via NF-kB signaling pathway and RANKL-induced osteoclastogenesis and Ti particle-induced periprosthetic osteolysis via JNK signaling pathways.
In summary, forsythiaside could inhibit osteoclastogenesis while inhibiting the particle-induced inammation, resulting in decreased secretion of inammatory cytokines, such as TNF-a, IL-1b, and inhibited the TNF-a-, IL-1b-induced osteoclastogenesis. On the other hand, forsythiaside inhibited the RANKLinduced osteoclastogenesis and Ti particle-induced periprosthetic osteolysis via JNK signaling pathway. Both the abovementioned biofunctions of forsythiaside contributed to the implant-associated particle-induced osteolysis. Thus, forsythiaside can act as a candidate for the precaution of implantassociated particle-induced osteolysis. Proteins were extracted after the co-culture of particles with THP-1 cells, and the NF-kB signaling pathway was characterized by western blotting (*P < 0.05). FA denote forsythiaside.
